Source Record
The History of FDA's Role in Preventing the Spread of HIV/AIDS
Why this source is used
FDA history exhibit covering the 1987 approval of zidovudine (AZT), ACT UP pressure on drug approval, and later HIV treatment milestones.
Start with the answer
Source Status
- Publisher
- U.S. Food and Drug Administration
- Type
- government
- Reliability
- high
- Cited by
- 8 pages
Source Links
Used by Topics
Used by Questions
Used by Timeline Events
ACT UP Founded in New York
Following a speech by playwright Larry Kramer, approximately 300 people gathered at the Lesbian and Gay Community Services Center in New York to form ACT UP (AIDS Coalition to Unleash Power). Their first major demonstration on Wall Street demanded greater access to experimental AIDS drugs. ACT UP's confrontational tactics transformed AIDS activism and influenced protest movements worldwide.
AZT Approved as First Antiretroviral Drug for HIV/AIDS
The US FDA approved zidovudine (AZT) for use against HIV/AIDS, making it the first antiretroviral drug available. The approval came just 25 months after AZT was first shown to be active against HIV — a record-breaking timeline. While a crucial breakthrough demonstrating HIV could be treated, AZT had significant side effects and limited efficacy when used alone, and was at the time the most expensive drug in history.
FDA Approves PrEP for HIV Prevention
The US FDA approved Truvada for use as pre-exposure prophylaxis (PrEP) in HIV-negative adults at high risk of infection — the first drug approved specifically for HIV prevention in uninfected individuals. PrEP represented a paradigm shift in HIV prevention, giving people a pharmaceutical tool to protect themselves, and has since been credited with significantly reducing new HIV infections where widely available.